228 results on '"Tailleux, Anne"'
Search Results
2. Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis
3. Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption
4. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
5. Corrigendum to “Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis” [Mol Metab 69 (2023) 1–13]
6. The hepatic compensatory response to elevated systemic sulfide promotes diabetes
7. NASH-related increases in plasma bile acid levels depend on insulin resistance
8. Endothelial Dysfunction and Pre-Existing Cognitive Disorders in Stroke Patients.
9. Multi-Omics Data Integration Reveals Sex-Dependent Hippocampal Programming by Maternal High-Fat Diet during Lactation in Adult Mouse Offspring
10. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
11. Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH
12. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids
13. Reduction of Atherosclerosis in Apolipoprotein E Knockout Mice by Activation of the Retinoid X Receptor
14. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1
15. The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity
16. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
17. Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly
18. Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation
19. Enterohepatic, gluco-metabolic, and gut microbial characterization of individuals with bile acid malabsorption
20. Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism
21. p16INK4a deficiency promotes IL-4–induced polarization and inhibits proinflammatory signaling in macrophages
22. Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model
23. Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System
24. Host Glucose Metabolism Mediates T4 and Il-7 Action on Schistosoma mansoni Development
25. Hypothalamic bile acid-TGR5 signaling protects from obesity
26. The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
27. The ALGOVUE Clinical Trial: Effects of the Daily Consumption of Eggs Enriched with Lutein and Docosahexaenoic Acid on Plasma Composition and Macular Pigment Optical Density
28. Short Article Hypothalamic bile acid-TGR5 signaling protects from obesity
29. Cdkn2a/p16Ink4a Regulates Fasting-Induced Hepatic Gluconeogenesis Through the PKA-CREB-PGC1α Pathway
30. Characterization of one anastomosis gastric bypass and impact of biliary and common limbs on bile acid and postprandial glucose metabolism in a minipig model
31. Plasma BCAA changes in Patients with NAFLD are Sex Dependent 1
32. The hepatic compensatory response to elevated systemic sulfide impairs medium chain fat oxidation and promotes diabetes
33. Multiple Selection Criteria for Probiotic Strains with High Potential for Obesity Management
34. Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production
35. Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice
36. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model
37. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
38. Inflammation‐induced cholestasis in cancer cachexia
39. Deletion of fibroblast activation protein provides atheroprotection
40. Transcription profiling in the liver of undernourished male rat offspring reveals altered lipid metabolism pathways and predisposition to hepatic steatosis
41. Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins
42. PS1 - 2. Role of the tumour suppressor CDKN2A/p16INK4a in the development of perivascular adipose tissue
43. Deletion of fibroblast activation protein provides atheroprotection.
44. Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null Mice
45. Peroxisome Proliferator-activated Receptor α Is Not Rate-limiting for the Lipoprotein-lowering Action of Fish Oil
46. Inflammation‐induced cholestasis in cancer cachexia.
47. Tau deletion promotes brain insulin resistance
48. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD Short title: Bile acids in meta-inflammatory disorders
49. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase
50. The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.